A new statistical analysis of patients with follicular lymphoma, made possible by 15 years of follow-up data from a SWOG and ...

Cure rate of 42% estimated in cure modeling; highest rate seen for patients with low Follicular Lymphoma International Prognostic Index scores.

Twenty years. That's how long Robert Oman has been cancer-free, thanks to a clinical trial offered at the University of ...

“[I thought] I had an intolerance to vodka," said Claire Dougherty ...

Before any major health crisis, there are symptoms that the body sends that shouldn’t be ignored. A doctor shared some such ...

Ipsen telegraphed plans to acquire Epizyme and the FDA-approved Tazverik in June 2022, two years after the med’s clearance in the U.S. as both an epithelioid sarcoma and follicular lymphoma treatment.

Debi Weiss thought her fatigue and weakness was a seasonal illness, but her condition quickly worsened.

The cancer drug tazemetostat (Tazverik) is being voluntarily withdrawn in the U.S. and all other markets over concerns about secondary cancers, drugmaker Ipsen announced. The company also said it is ...

Jana Batson was diagnosed with Hodgkin lymphoma after she insisted upon having a swollen lymph node examined. In addition to ...

PARIS, FRANCE, 09 March 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it is voluntarily withdrawing Tazverik (tazemetostat) in all indications from all Ipsen markets. Ipsen's decision ...

In August 2025, Edd Vieira, an engineer from Northamptonshire, England, was on vacation visiting his family in Portugal when ...

But I'm not sure what the intermediate stages are.